Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrence Hepatocellular Carcinoma”

487 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 487 results

Large-scale testing (Phase 3)Study completedNCT00692770
What this trial is testing

Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)

Who this might be right for
Carcinoma, Hepatocellular
Bayer 1,114
Not applicableStudy completedNCT00059267
What this trial is testing

Prevention of Recurrent Hepatitis B After Liver Transplantation

Who this might be right for
Hepatitis BCirrhosisAcute Liver Failure+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 317
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT00077142
What this trial is testing

TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

Who this might be right for
Liver Cancer
M.D. Anderson Cancer Center 37
Large-scale testing (Phase 3)UnknownNCT05250843
What this trial is testing

TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC

Who this might be right for
Hepatocellular Carcinoma
Third Affiliated Hospital, Sun Yat-Sen University 90
Not applicableLooking for participantsNCT06653062
What this trial is testing

Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance

Who this might be right for
Hepatocellular Carcinoma (HCC)
Tongji Hospital 50
Large-scale testing (Phase 3)Study completedNCT01640808
What this trial is testing

Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC

Who this might be right for
Hepatic Neoplasm Malignant Recurrent
Kowa Company, Ltd. 616
Testing effectiveness (Phase 2)Study completedNCT00083226
What this trial is testing

Doxorubicin and Bortezomib in Treating Patients With Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 42
Not applicableUnknownNCT03356236
What this trial is testing

Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation

Who this might be right for
Hepatocarcinoma
Yue Han 828
Not applicableStudy completedNCT06776185
What this trial is testing

Recurrence Patterns and Cost-Effectiveness of Surgical Approaches in Early-Stage Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Chen Xiaoping 3,000
Testing effectiveness (Phase 2)Ended earlyNCT00085410
What this trial is testing

Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder

Who this might be right for
Adenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderAdvanced Adult Primary Liver Cancer+7 more
National Cancer Institute (NCI) 20
Not applicableLooking for participantsNCT06581315
What this trial is testing

Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaAdjuvant Therapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 204
Testing effectiveness (Phase 2)Looking for participantsNCT06454578
What this trial is testing

Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection

Who this might be right for
Carcinoma, Hepatocellular
Qilu Hospital of Shandong University 30
Large-scale testing (Phase 3)UnknownNCT04237740
What this trial is testing

Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation

Who this might be right for
Hepatocellular CarcinomaLiver Transplantation
RenJi Hospital 40
Not applicableStudy completedNCT00397540
What this trial is testing

The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)

Who this might be right for
Carcinoma, HepatocellularChronic Hepatitis B
Seoul National University Hospital 145
Very early researchNot Yet RecruitingNCT07709299
What this trial is testing

Safety and Feasibility of CIK Cell Therapy in HCC After Tumor Resection

Who this might be right for
Hepatocellular Carcinoma (HCC)
Royan Institute 6
Testing effectiveness (Phase 2)Ended earlyNCT03945799
What this trial is testing

Study of Anlotinib in Hepatocellular Carcinoma (HCC) Patients at High Risk of Post Surgery Recurrence

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 28
Testing effectiveness (Phase 2)Study completedNCT00009893
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Alliance for Clinical Trials in Oncology 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT03836352
What this trial is testing

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

Who this might be right for
Ovarian CancerHepatocellular CarcinomaNon-small Cell Lung Cancer+2 more
ImmunoVaccine Technologies, Inc. (IMV Inc.) 184
Next Page